Inteliview
Log inSign up
IPO Tracker
M

Mountain Crest Acquisition 6 Corp.

Mountain Crest Acquisition 6 Corp.

USListed
Valuation$69M
Listed DateApril 6, 2026
SectorN/A
Exchange--
RELATED IPOS
L
Lakewood-Amedex Biotherapeutics Inc.Lakewood-Amedex Biotherapeutics Inc.N/A · --
G
General Catalyst Global Resilience Merger Corp.General Catalyst Global Resilience Merger Corp.N/A · $350M
Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc.Hemab Therapeutics Holdings, Inc.N/A · $302M
Avalyn Pharma Inc.
Avalyn Pharma Inc.Avalyn Pharma Inc.N/A · $300M
A
ARC Group Acquisition I Corp.ARC Group Acquisition I Corp.N/A · $105M
SILVER BOW MINING CORP.
SILVER BOW MINING CORP.SILVER BOW MINING CORP.N/A · $65M
FAQ

When is the Mountain Crest Acquisition 6 Corp. IPO expected?

Mountain Crest Acquisition 6 Corp. has already gone public. It listed on April 6, 2026.

What is Mountain Crest Acquisition 6 Corp.'s valuation?

Mountain Crest Acquisition 6 Corp.'s estimated valuation is approximately $69M. It operates in the N/A sector. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Mountain Crest Acquisition 6 Corp. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.